The five most popular items of December
Click Here to Manage Email Alerts
Orthopedics Today has put together a compilation of the five news stories and videos most viewed from December 2014 to keep you abreast of the current hot topics in orthopedics.
Study: Angular stable locking system offers little benefit for treating distal tibial fractures
Recently published data showed treating distal tibial fractures using an angular stable locking treating with intramedullary nailing offered no benefit in terms of patient outcomes compared with traditional locking screws. Read more.
Study results show incidence of ACL reconstruction has increased significantly
According to recent study data, the number of ACL reconstructions has risen significantly between 1994 and 2006, particularly in women younger than 20 years of age and older than 40 years of age. Read more.
Speaker: High metal ion levels, persistent pain among indications for revision of MoM hips
ORLANDO, Fla. – Elevated metal ion levels, loose cups either radiographically or clinically and psychological changes are among the indications orthopedic surgeons need to consider for the revision of metal-on-metal hip articulations, according to a presenter at the Current Concepts in Joint Replacement Winter Meeting. Read more.
PRP injection may aid in rehabilitation of hamstring injury
Recently published data indicated a program of rehabilitation and platelet-rich plasma therapy may be more beneficial in patients with an acute hamstring injury than rehabilitation alone. Read more.
Barrack offers a perspective on use of mobile compression device for thrombosis prevention after TJA
ORLANDO, Fla. — At the Current Concepts in Joint Replacement Winter Meeting, Robert L. Barrack, MD, shares his perspective on a study of the use of a mobile compression device for the prevention of symptomatic venous thromboembolic events after primary unilateral total joint arthroplasty. Researchers concluded that the use of the mobile compression device with or without aspirin for provided a non-inferior risk for the development of venous thromboembolism compared with current pharmacological protocols. Watch video.